Horizon Kinetics Medical ETF (MEDX)

MEDX Holdings Information

MEDX has a total of 39 holdings and holds stocks. The top 10 holdings account for 54.36% of the fund's assets.

• Holdings Count: 39
• Total Assets: $19.44M
• Top 10 Percentage: 54.36%
• Asset Class: Equity
• Region: n/a
• PE Ratio: n/a

Holdings List

As of May 30, 2023

Filter results

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	8.06%	3,641
2	BMY	Bristol-Myers Squibb Company	6.35%	19,245
3	ABBV	AbbVie Inc.	5.88%	8,322
4	PFE	Pfizer Inc.	5.39%	28,088
5	BIIB	Biogen Inc.	5.23%	3,381
6	NVSN.MX	Novartis AG ADR	5.20%	10,403
7	AZN	AstraZeneca PLC	5.01%	13,524
8	JNJ	Johnson & Johnson	4.99%	6,241
9	AMGN	Amgen Inc.	4.12%	3,641
10	MRK	Merck & Co., Inc.	4.12%	7,282
11	CRSP	CRISPR Therapeutics AG	3.83%	11,443
12	ALKS	Alkermes plc	3.78%	24,967
13	GILD	Gilead Sciences, Inc.	3.70%	9,362
14	SNY	Sanofi	3.54%	13,524
15	NTLA	Intellia Therapeutics, Inc.	3.04%	15,604
16	ALNY	Alnylam Pharmaceuticals, Inc.	3.01%	3,120
17	REGN	Regeneron Pharmaceuticals, Inc.	2.94%	780
18	IONS	Ionis Pharmaceuticals, Inc.	2.84%	13,524
19	GSK	GSK plc	2.14%	12,211
20	BCYC	Bicycle Therapeutics plc	1.94%	15,604
21	n/a	US BANK MMDA - USBGFS 7	1.73%	333,815
22	BEAM	Beam Therapeutics Inc.	1.72%	10,403
23	EDIT	Editas Medicine, Inc.	1.59%	34,330
24	REPL	Replimune Group, Inc.	1.50%	15,604
25	TSVT	2seventy bio, Inc.	1.16%	18,725
26	LTRN	Lantern Pharma Inc.	0.88%	31,209
27	OGN	Organon & Co.	0.87%	8,738
28	VNDA	Vanda Pharmaceuticals Inc.	0.87%	28,088
29	PACB	Pacific Biosciences of California, Inc.	0.80%	12,483
30	BLUE	bluebird bio, Inc.	0.68%	39,532
31	HLN	Haleon plc	0.64%	15,264
32	ALLO	Allogene Therapeutics, Inc.	0.56%	20,806
33	GALT	Galectin Therapeutics Inc.	0.49%	58,258
34	GEHC	GE HealthCare Technologies Inc.	0.42%	1,040
35	n/a	DEPOSITS WITH BROKER FOR SHORT POSITIONS	0.38%	73,556
36	SLRX	Salarius Pharmaceuticals, Inc.	0.25%	33,706
37	VTRS	Viatris Inc.	0.18%	3,872
38	RAIN	Rain Therapeutics Inc.	0.15%	26,008
39	IMNPQ	Immune Pharmaceuticals Inc	0.00%	1

As of May 30, 2023